Literature DB >> 669578

A radioimmunoassay for measurement of human pancreatic secretory trypsin inhibitor in different body fluids.

A Eddeland, K Ohlsson.   

Abstract

A radioimmunoassay for measurement of human pancreatic secretory trypsin inhibitor in nanogram quantities has been developed. The sensitivity of the assay now permits examination of the inhibitor content of various body fluids, wherein other methods exhibit serious short-comings. In healthy blood donors the serum level was 8.1 microgram/l. In patients with acute pancreatitis levels as high as 320 microgram/l have been measured, and patients who underwent endoscopic retrograde cholangiopancreatography showed an elevated inhibitor level in serum immediately after the examination without any clinical signs of disease, the highest registered value being 128 microgram/l. In peritoneal lavage fluid from patients with severe acute pancreatitis levels of 5-304 microgram/l have been measured. In urine the inhibitor level is about 14 microgram/l in healthy persons. The urine from one patient with proteinuria of glomerulo-tubular type contained 380 microgram/l.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 669578     DOI: 10.1515/bchm.1978.359.1.671

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  14 in total

1.  Measurements of exocrine proteins in the pig pancreas using microdialysis.

Authors:  P Jönsson; A Borgström; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1992-08

2.  Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1991-02

3.  Production and secretion of pancreatic secretory trypsin inhibitor in normal human small intestine.

Authors:  H Bohe; M Bohe; E Lundberg; A Polling; K Ohlsson
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

Review 4.  Acute necrotising pancreatitis--a role for enterokinase.

Authors:  D Grant
Journal:  Int J Pancreatol       Date:  1986-10

5.  Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases.

Authors:  M Plebani; D Basso; C Fabris; T Meggiato; G Del Favero; M P Panozzo; P Fogar; D Faggian; C Angonese; A Burlina
Journal:  Klin Wochenschr       Date:  1989-10-17

6.  Appearance mechanism and molecular heterogeneity of serum pancreatic secretory trypsin inhibitor (PSTI).

Authors:  I Nakano; A Funakoshi; T Sumii; K Miyazaki; Y Oogami; T Kimura; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1985-08

7.  Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor.

Authors:  Y Ohmachi; A Murata; N Matsuura; T Yasuda; K Uda; T Mori
Journal:  Int J Pancreatol       Date:  1994-02

8.  Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.

Authors:  Alexander Gaber; Björn Nodin; Kristina Hotakainen; Elise Nilsson; Ulf-Håkan Stenman; Anders Bjartell; Helgi Birgisson; Karin Jirström
Journal:  BMC Cancer       Date:  2010-09-17       Impact factor: 4.430

9.  Elevated serum levels of pancreatic secretory proteins in cigarette smokers after secretin stimulation.

Authors:  G Balldin; A Borgström; A Eddeland; S Genell; L Hagberg; K Ohlsson
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

10.  Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.

Authors:  R Berling; A Borgström; K Ohlsson
Journal:  Int J Pancreatol       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.